1. P09.05 Immunogenicity induced by the academic chimeric antigen receptor CAR19 (ARI-0001) in patients with CD19-positive relapsed/refractory B-cell malignancies recruited into the CART19-BE-01 clinical trial. (1st October 2020) Authors: Klein-González, N; González-Navarro, EA; Bartoló-Ibars, A; Ortiz-Maldonado, V; Torrebadell, M; Castellà, M; Benítez, D; Caballero-Baños, M; Cabezón, R; Español, M; Baumann, T; Giné, E; Castro, P; Esteve, J; Yagüe, J; Rives, S; Urbano-Ispizua, Á Álvaro; Delgado, J; Juan, M Journal: Journal for immunotherapy of cancer Issue: Volume 8(2020)Supplement 2 Page Start: A54 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. PD-031Immune signatures identify three immune clusters in mCRC, with potential clinical implications. (2nd July 2019) Authors: Pedrosa, L; Moreno, R; Esposito, F; Jares, P; Cuatrecasas, M; Pineda, E; Español, M; Paré, L; De la Iglesia, N; Benitez, D; Camps, J; Church, S; Cascante, M; Thomson, T; Prat, A; Maurel, J Journal: Annals of oncology Issue: Volume 30(2019)Supplement 4 Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗